Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Frontiers in Oncology|January 22, 2016
Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung CancerChao H Huang, Stephen K Williamson, Prakash Neupane, et al.Pulmonary Circulation|June 10, 2025
The Role of Telehealth in PAH Management: Benefits, Barriers, and SolutionsSusanne McDevitt, Martha Kingman, Lana Melendres Groves, et al.Injury|January 27, 2019
Identifying areas for improvement in paediatric trauma care in NSW Australia using a clinical, system and human factors peer-review toolKate Curtis, Belinda Kennedy, Andrew J A Holland, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 20, 2024
Could primary care records be used to identify women at risk of perinatal anxiety? A mixed-methods studyTamsin Fisher, Charlotte Archer, James Bailey, et al.Blood|May 8, 2015
VPS33B regulates protein sorting into and maturation of α-granule progenitor organelles in mouse megakaryocytesDanai Bem, Holly Smith, Blerida Banushi, et al.Virchows Archiv : an International Journal of Pathology|April 27, 2007
Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic countOssama Tawfik, Bruce F Kimler, Marilyn Davis, et al.Thorax|July 7, 2019
Antimicrobial peptides, disease severity and exacerbations in bronchiectasisOriol Sibila, Lídia Perea, Elisabet Cantó, et al.Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.Proceedings. Biological Sciences|November 24, 2021
Growth of Neanderthal infants from Krapina (120-130 ka), CroatiaPatrick Mahoney, Gina McFarlane, B Holly Smith, et al.Regulatory Toxicology and Pharmacology : RTP|April 7, 2009
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studiesRafael Ponce, Leslie Abad, Lakshmi Amaravadi, et al.Pageof 9